The Dopamine D 1 Receptor and Angiotensin II Type-2 Receptor are Required for Inhibition of Sodium Transport Through a Protein Phosphatase 2A Pathway-Reference-Cited by-同舟云学术

The Dopamine D 1 Receptor and Angiotensin II Type-2 Receptor are Required for Inhibition of Sodium Transport Through a Protein Phosphatase 2A Pathway

Published:2019-06 Issue:6 Volume:73 Page:1258-1265
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Gildea John J.¹,Xu Peng¹,Kemp Brandon A.²,Carey Robert M.²,Jose Pedro A.³,Felder Robin A.¹

Affiliation:

1. From the Departments of Pathology (J.J.G., P.X., R.A.F.)

2. Medicine (B.A.K., R.M.C.), University of Virginia, Charlottesville, VA

3. Division of Renal Disease & Hypertension Departments of Medicine and Pharmacology/Physiology, The George Washington University School of Medicine and Health Sciences, Washington DC (P.A.J.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference42 articles.

1. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney

2. In hypertension, the kidney rules

3. The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease

4. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.;Olsen NV;Dan Med Bull,1998

5. Mechanisms of Disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the brain renin-angiotensin system in Parkinson´s disease;Translational Neurodegeneration;2024-04-15

2. Role of Dopamine in the Heart in Health and Disease;International Journal of Molecular Sciences;2023-03-06

3. Untargeted Metabolomics Analysis Using UHPLC-Q-TOF/MS Reveals Metabolic Changes Associated with Hypertension in Children;Nutrients;2023-02-06

4. Inverse Salt Sensitivity of Blood Pressure Is Associated with an Increased Renin-Angiotensin System Activity;Biomedicines;2022-11-04

5. The Angiotensin AT₂Receptor: From a Binding Site to a Novel Therapeutic Target;Pharmacological Reviews;2022-09-30